With over 60 brands like Siduri, Novy, Chardenet, and its highest selling brand of super-premium wines – the Kendall-Jackson, there is no slowing down in the continuous success of the Jackson Family Wines.
As the company expands its reach to a new generation of wine drinkers, tapping Julia Jackson as its spokesperson is a no brainer. She pursued her graduate studies at Stanford School of Business after receiving her bachelor’s degree in Studio Art from Scripps College. Part of her responsibilities in the family’s company is introducing the Jackson Family Wines to aficionados around the world while working alongside the international sales team.
View more: https://www.pinterest.com/juliajacksonca/
Being one of the second generation proprietors of the Jackson Family Wines, she always had a strong affinity with wines; the Cabernet that thrives in Sonoma County is her preferred varietal. Growing up in vineyards throughout her childhood and now taking part of the role in maintaining the outstanding reputation of the family’s wine business, she has honed her craft from her lifelong dedication in learning every aspect of the family’s wine making business.
Also taking cue from her parents’ philanthropic activities, Julia founded Cambria Seeds of Empowerment in 2014. It’s a program that gives annual donations of $100, 000 to nonprofit organizations whose main focus is to help succeed women in their communities.
While Julia has the natural charm to rub elbows with the elites, her fresh perspective to the decades old business has provided significant contribution to the Jackson Family Wines’ heritage.
Scott Rocklage has served as Chairman and CEO of Cubist Pharmaceuticals. He was also President, and CEO of Nycomed Salutar, a company that makes biopharmaceuticals. He has lead the research and development of three FDA-approved drugs: Omniscan, Teslascan, and Cubicin. Dr. Scott Rocklage has over thirty years of management experience within the healthcare industry.
Dr. Rocklage received a Bachelor of Science degree in Chemistry from Berkeley, The University of California and then went on to get his Ph.D. in Chemistry from the Massachusetts Institute of Technology(MIT). His insight and knowledge have helped to shape the pharmaceutical industry. Teslascan and Omniscan are both drugs that are injected intravenously, they are used to make lesions of the kidneys and liver, respectively, more visible.
How has Dr.Rocklage been able to do so much? In a recent interview, with ideamensch.com, Rocklage has said, “I am very well organized with regards to time management, calendaring and prioritization”.
5 AM Ventures
Rocklage has recently started a venture capital firm named “5 AM Ventures“. This venture capital firm funds biomedical start-ups in particular. Dr. Rocklage bets on the best companies he can find, some of them have come up with great products. The one that stands out the most is the needle-less injector, the Portal Prime. With the help of Dr.Rocklage’s firm, Portal Instruments was able to develop the Portal Prime. How does it work?
The Portal Prime delivers medication subcutaneously, intradermally, or intramuscularly. Rocklage on LinkedIn.
I can definitely imagine this being widely accepted first by pediatricians. Along with being easy to use, The Portal Prime also has been designed to integrate itself with an online app that can be accessed by third parties, like doctors, pharmacies, and insurers. These third parties can have a record of the data gathered by the device, and save it for future reference. Having all the information on one app would also make patient treatment seamless since doctors would be able to track a patient’s progress from their phone.